A carregar...
Dapagliflozin Lowers Plasma Glucose Concentration and Improves β-Cell Function
BACKGROUND: β-Cell dysfunction is a core defect in T2DM, and chronic, sustained hyperglycemia has been implicated in progressive β-cell failure, ie, glucotoxicity. The aim of the present study was to examine the effect of lowering the plasma glucose concentration with dapagliflozin, a glucosuric age...
Na minha lista:
| Publicado no: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4422889/ https://ncbi.nlm.nih.gov/pubmed/25710563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-3472 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|